查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589603

药物释放型支架市场：药物涂层，按应用分类 - 全球预测 2025-2030

Drug Eluting Stent Market by Drug Coating (Polymer Free Coatings, Polymer-Based Coatings), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

药物释放型支架市场2023年估值为72.7亿美元，预计2024年将达到80.5亿美元，复合年增长率为10.84%，预计到2030年将达到149.4亿美元。

药物释放型支架 (DES) 是介入性心臟病学中用于预防冠状动脉粥状硬化阻塞復发的专用冠状动脉支架。这些支架上涂有药物，缓慢释放的药物抑制细胞增殖，有效维持血管通畅性。对 DES 的需求源于需要透过最大限度地减少血管再阻塞（一种与裸金属支架相关的常见併发症）来改善经经皮冠状动脉介入治疗的结果。 DES 广泛应用于心臟病学，也延伸到冠状动脉疾病的治疗，医院和心臟中心是主要的最终用户。 DES 市场的主要成长要素包括全球心血管疾病盛行率上升、人口老化以及提高支架有效性和生物相容性的技术进步。此外，正在进行的新型药物配方和生物可吸收支架的研究也带来了有希望的成长机会。为了保持竞争力，公司可以探索策略伙伴关係并投资研究以开发下一代支架。然而，市场开拓面临严格的监管要求、DES 的高成本和报销问题等挑战，阻碍了采用，特别是在新兴经济体。另一个潜在的限制是併发症的发生，例如支架晚期血栓症和需要延长双联抗血小板治疗。为了抓住新的机会，公司应该专注于药物包衣的创新，推广生物分解性的选择，并透过发展医疗基础设施来拓展开拓的市场。在产品开发的积极研发以及旨在扩大市场占有率的频繁併购的推动下，市场竞争仍然激烈。成功的关键在于平衡创新和成本效益、回应监管环境并有效解决病人安全问题。透过策略性地瞄准新兴市场并投资最尖端科技，公司可以在药物释放型支架的动态格局中充分利用巨大的成长潜力。

主要市场统计
基准年[2023] 72.7亿美元
预测年份 [2024] 80.5亿美元
预测年份 [2030] 149.4亿美元
复合年增长率（%） 10.84%

市场动态：快速发展的药物释放型支架市场的关键市场洞察

药物释放型支架市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 由于动脉疾病的风险增加，老年人口不断增加
    • 动脉硬化盛行率上升
    • 糖尿病和心臟麻痹等慢性病盛行率增加
  • 市场限制因素
    • 与药物释放型支架相关的风险
  • 市场机会
    • 透过引入生物可吸收支架支持微创手术
    • 改善新兴国家的医疗基础设施
  • 市场挑战
    • 产品召回问题

波特的五力：驾驭药物释放型支架市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物释放型支架市场的外部影响

外部宏观环境因素对药物释放型支架市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药物释放型支架市场的竞争格局

药物释放型支架市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV定位矩阵药物释放型支架市场供应商绩效评估

FPNV定位矩阵是评估药物释放型支架市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製药物释放型支架市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，药物释放型支架市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着人口老化的加剧，动脉疾病的风险也增加。
      • 动脉硬化盛行率上升
      • 糖尿病和心臟麻痹等慢性疾病增加
    • 抑制因素
      • 与药物释放型支架相关的风险
    • 机会
      • 生物可吸收支架的引入使微创手术成为可能
      • 改善新兴国家的医疗基础设施
    • 任务
      • 产品召回问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章药物释放型支架市场药物涂层

  • 无聚合物涂层
    • 微孔表面
    • 微结构表面
    • 奈米多孔表面
    • 开槽管状表面
  • 聚合物基涂料
    • 生物分解性聚合物
    • 非生物分解的聚合物

第七章药物释放型支架市场：依应用分类

  • 冠状动脉疾病
  • 周边动脉疾病

第八章美洲药物释放型支架市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太药物释放型支架市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲药物释放型支架市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Alvimedica
  • Arkray, Inc.
  • B. Braun
  • Biosensors International Group, Ltd.
  • Biotronik
  • Boston Scientific Corporation
  • Cook Medical LLC
  • HEXACATH
  • KYOTO MEDICAL PLANNING Co., Ltd.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • REVA Medical LLC
  • Shandong JW Medical Systems LTD.
  • Terumo Corporation
Product Code: MRR-807A20B5CCC6

The Drug Eluting Stent Market was valued at USD 7.27 billion in 2023, expected to reach USD 8.05 billion in 2024, and is projected to grow at a CAGR of 10.84%, to USD 14.94 billion by 2030.

Drug-eluting stents (DES) are specialized coronary stents used in interventional cardiology to prevent the recurrence of arteriosclerotic blockages in coronary arteries. These stents are coated with medication that is gradually released to inhibit cell proliferation, thus maintaining vessel patency effectively. The necessity for DES arises from the need to improve outcomes of percutaneous coronary interventions by minimizing restenosis, a common complication associated with bare-metal stents. Widely utilized in cardiology, their applications extend to treating coronary artery disease, and hospitals and specialized cardiac centers represent the primary end-users. Key growth factors for the DES market include the rising prevalence of cardiovascular diseases globally, an aging population, and technological advancements that enhance stent efficacy and biocompatibility. Furthermore, ongoing research into novel drug formulations and bioresorbable stents offers promising growth opportunities. Companies could explore strategic partnerships and invest in research to develop next-generation stents to remain competitive. However, market growth faces challenges such as stringent regulatory requirements, high costs of DES, and reimbursement issues that could hinder adoption, especially in developing economies. Potential limitations also include complications like late stent thrombosis, necessitating extended dual antiplatelet therapy. To capture emerging opportunities, businesses should focus on innovation in drug coatings, promoting biodegradable options, and expanding in underserved markets with growing healthcare infrastructure. The market remains highly competitive, underscored by aggressive R&D in product development and frequent mergers and acquisitions aimed at expanding market share. Success relies on the ability to balance innovation with cost-effectiveness, navigating regulatory landscapes, and effectively addressing patient safety concerns. By strategically targeting emerging markets and investing in cutting-edge technologies, companies can leverage significant growth potential within the dynamic landscape of drug-eluting stents.

KEY MARKET STATISTICS
Base Year [2023] USD 7.27 billion
Estimated Year [2024] USD 8.05 billion
Forecast Year [2030] USD 14.94 billion
CAGR (%) 10.84%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Eluting Stent Market

The Drug Eluting Stent Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population along with growing high risk of developing arterial diseases
    • Rising prevalence rate of atherosclerosis
    • Increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
  • Market Restraints
    • Risks associated with drug eluting stent
  • Market Opportunities
    • Introduction of bio resorbable stents support minimally invasive surgeries
    • Improving healthcare infrastructure in emerging economies
  • Market Challenges
    • Issues related to product recall

Porter's Five Forces: A Strategic Tool for Navigating the Drug Eluting Stent Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Eluting Stent Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Eluting Stent Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Eluting Stent Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Eluting Stent Market

A detailed market share analysis in the Drug Eluting Stent Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Eluting Stent Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Eluting Stent Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Eluting Stent Market

A strategic analysis of the Drug Eluting Stent Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alvimedica, Arkray, Inc., B. Braun, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, Cook Medical LLC, HEXACATH, KYOTO MEDICAL PLANNING Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, REVA Medical LLC, Shandong JW Medical Systems LTD., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Stent Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Coating, market is studied across Polymer Free Coatings and Polymer-Based Coatings. The Polymer Free Coatings is further studied across Micro Porous Surface, Micro Structured Surface, Nanoporous Surface, and Slotted Tubular Surface. The Polymer-Based Coatings is further studied across Biodegradable Polymers and Non-Biodegradable Polymers.
  • Based on Application, market is studied across Coronary Artery Disease and Peripheral Artery Disease.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population along with growing high risk of developing arterial diseases
      • 5.1.1.2. Rising prevalence rate of atherosclerosis
      • 5.1.1.3. Increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
    • 5.1.2. Restraints
      • 5.1.2.1. Risks associated with drug eluting stent
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of bio resorbable stents support minimally invasive surgeries
      • 5.1.3.2. Improving healthcare infrastructure in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to product recall
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Eluting Stent Market, by Drug Coating

  • 6.1. Introduction
  • 6.2. Polymer Free Coatings
    • 6.2.1. Micro Porous Surface
    • 6.2.2. Micro Structured Surface
    • 6.2.3. Nanoporous Surface
    • 6.2.4. Slotted Tubular Surface
  • 6.3. Polymer-Based Coatings
    • 6.3.1. Biodegradable Polymers
    • 6.3.2. Non-Biodegradable Polymers

7. Drug Eluting Stent Market, by Application

  • 7.1. Introduction
  • 7.2. Coronary Artery Disease
  • 7.3. Peripheral Artery Disease

8. Americas Drug Eluting Stent Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Drug Eluting Stent Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Drug Eluting Stent Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alvimedica
  • 3. Arkray, Inc.
  • 4. B. Braun
  • 5. Biosensors International Group, Ltd.
  • 6. Biotronik
  • 7. Boston Scientific Corporation
  • 8. Cook Medical LLC
  • 9. HEXACATH
  • 10. KYOTO MEDICAL PLANNING Co., Ltd.
  • 11. Lepu Medical Technology (Beijing) Co., Ltd.
  • 12. Medtronic PLC
  • 13. Meril Life Sciences Pvt. Ltd.
  • 14. MicroPort Scientific Corporation
  • 15. REVA Medical LLC
  • 16. Shandong JW Medical Systems LTD.
  • 17. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. DRUG ELUTING STENT MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG ELUTING STENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG ELUTING STENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG ELUTING STENT MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MICRO POROUS SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MICRO STRUCTURED SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY NANOPOROUS SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY SLOTTED TUBULAR SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2023